Charles River Laboratories International, Inc.

Healthcare

NYSE:CRL · New York Stock Exchange

Market Cap $9.06B Beta 1.45 P/E (TTM) -49.9

$187.51 +0.13%

+$0.24 today

52W Low $143.06High $228.88

Vol 0.40M · Avg 0.88M

EPS (TTM)-$3.77

Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+25.47%

Period High

$226.77

Period Low

$145.05

Latest

$187.51

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.47B

Penumbra, Inc.

NYSE:PEN

$12.53B

Revvity, Inc.

NYSE:RVTY

$11.15B

Baxter International Inc.

NYSE:BAX

$10.76B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.72B

Qiagen N.V.

NYSE:QGEN

$7.66B

Avantor, Inc.

NYSE:AVTR

$6.54B

Caris Life Sciences, Inc.

NASDAQ:CAI

$5.07B

Atrium Therapeutics, Inc.

NASDAQ:RNA

$210.49M

What is the latest CRL filing?

The latest filing shown is 4 dated Jun 8, 2026.

How many recent filings does CRL have?

Intrinsic Alpha currently shows 20 recent filings for CRL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.